Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)

Trial Profile

Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs BMS 986094 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Acronyms CARE-HepC
  • Most Recent Events

    • 12 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 May 2014 Planned number of patients changed from 500 to 160 as reported by ClinicalTrials.gov.
    • 10 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top